Risto Ala‐aho

3.1k citations
27 papers · 2.6k indexed · 1 hit paper · h-index 23

Risto Ala‐aho

27 papers receiving 2.5k citations

Hit Papers

CIP2A Inhibits PP2A in Human Malignancies5332007202620132019100200300400500

Peers

Risto Ala‐aho
Comparison fields: 5 of 110
  • Cancer Research 977
  • Immunology and Allergy 264
  • Oncology 942
  • Hematology 224
  • Molecular Biology 1.3k
Replace María Jiménez with:
María Jiménez Spain
Hervé Emonard France
Tetsuro Ikebe Japan
William T. Roswit United States
Ulrike Benbow United States
Lars H. Engelholm Denmark
G. A. Bannikov United States
George P. Stricklin United States
Tatsuo Senshu Japan
Jo Louise Seltzer United States
Risto Ala‐aho relative to María Jiménez Spain María Jiménez's profile →
Citations per field
00.5×1.5×2.0×
María Jiménez · 1×
Citations per year

Countries citing papers authored by Risto Ala‐aho

Since Specialization
Citations

This map shows the geographic impact of Risto Ala‐aho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risto Ala‐aho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risto Ala‐aho more than expected).

Fields of papers citing papers by Risto Ala‐aho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risto Ala‐aho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risto Ala‐aho. The network helps show where Risto Ala‐aho may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Risto Ala‐aho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Risto Ala‐aho Line = papers co-authored together Risto Ala‐aho links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 201545
2 201465
3 201375
4 201172
5 201155
6 201059
7 200929
8 200817
9 20083
10
CIP2A Inhibits PP2A in Human Malignanciesbreakdown →
2007533
11 2007114
12 200652
13 2005272
14 2005230
15 200469
16 200259
17 200284
18 200265
19 200145
20 200082

About Risto Ala‐aho

Risto Ala‐aho is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 27 papers that have together received 2.6k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (14 papers), Peptidase Inhibition and Analysis (9 papers), TGF-β signaling in diseases (5 papers), Cell Adhesion Molecules Research (5 papers), NF-κB Signaling Pathways (4 papers), Immunotherapy and Immune Responses (3 papers), Hedgehog Signaling Pathway Studies (2 papers) and Nail Diseases and Treatments (2 papers). The work is most often cited by research in Cancer Research (977 citations), Immunology and Allergy (264 citations) and Oncology (942 citations). Risto Ala‐aho has collaborated with scholars based in Finland, United Kingdom and United States. Frequent co-authors include Veli‐Matti Kähäri, Reidar Grénman, Pia Vihinen, Juha Peltonen, Markku Kallajoki, Nina Johansson, Ulpu Saarialho‐Kere, Melissa R. Junttila, Jukka Westermarck and Norbert E. Fusenig. Their work appears in journals such as Cell, PLoS ONE and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026